Search Results

There are 15957 results for: content related to: Complementary and alternative medicine in chronic liver disease

  1. You have free access to this content
    Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid


    Volume 32, Issue 5, November 2000, Pages: 897–900, Paul Angulo, Tushar Patel, Roberta A. Jorgensen, Terry M. Therneau and Keith D. Lindor

    Article first published online : 30 DEC 2003, DOI: 10.1053/jhep.2000.18663

  2. You have free access to this content
    Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: A study in vivo and in isolated hepatocyte couplets


    Volume 34, Issue 2, August 2001, Pages: 329–339, Fernando A. Crocenzi, Enrique J. Sánchez Pozzi, José M. Pellegrino, Cristín O. Favre, Emilio A. Rodríguez Garay, Aldo D. Mottino, Roger Coleman and Marcelo G. Roma

    Article first published online : 30 DEC 2003, DOI: 10.1053/jhep.2001.26520

  3. You have free access to this content
    Herbal products for liver diseases: A therapeutic challenge for the new millennium


    Volume 30, Issue 4, October 1999, Pages: 1099–1104, Detlef Schuppan, Ji-Dong Jia, Benno Brinkhaus and Eckhart G. Hahn

    Article first published online : 30 DEC 2003, DOI: 10.1002/hep.510300437

  4. You have free access to this content
    Silymarin: What is in the name …? An appeal for a change of editorial policy


    Volume 32, Issue 2, August 2000, Pages: 442–444, Vilím Šimánek, Vladimír Kren, Jitka Ulrichová, Jaroslav Vicar and Ladislav Cvak

    Article first published online : 30 DEC 2003, DOI: 10.1053/jhep.2000.9770

  5. Silymarin inhibits melanoma cell growth both in vitro and in vivo by targeting cell cycle regulators, angiogenic biomarkers and induction of apoptosis

    Molecular Carcinogenesis

    Volume 54, Issue 11, November 2015, Pages: 1328–1339, Mudit Vaid, Tripti Singh, Ram Prasad and Santosh K. Katiyar

    Article first published online : 30 AUG 2014, DOI: 10.1002/mc.22208

  6. The flavonolignan-silymarin protects enzymatic, hematological, and immune system against γ-radiation-induced toxicity

    Environmental Toxicology

    Manish Adhikari and Rajesh Arora

    Article first published online : 20 NOV 2014, DOI: 10.1002/tox.22076

  7. You have free access to this content
    Clinical studies with silymarin: Fibrosis progression is the end point


    Volume 33, Issue 2, February 2001, Pages: 483–484, Detlef Schuppan and Eckhart G. Hahn

    Article first published online : 30 DEC 2003, DOI: 10.1002/hep.510330230

  8. Silymarin attenuates paraquat-induced lung injury via Nrf2-mediated pathway in vivo and in vitro

    Clinical and Experimental Pharmacology and Physiology

    Volume 42, Issue 9, September 2015, Pages: 988–998, Feng Zhao, Danyang Shi, Tiegang Li, Lizhuo Li and Min Zhao

    Article first published online : 25 AUG 2015, DOI: 10.1111/1440-1681.12448

  9. Silymarin potentiates the antinociceptive effect of morphine in mice

    Phytotherapy Research

    Volume 25, Issue 2, February 2011, Pages: 250–255, Hassan Malekinejad, Maysam Taheri-Broujerdi, Masumeh Moradi and Seyed-Hamed Tabatabaie

    Article first published online : 16 JUL 2010, DOI: 10.1002/ptr.3251

  10. You have free access to this content
    Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection


    Volume 57, Issue 3, March 2013, Pages: 1262–1271, Stephen J. Polyak, Peter Ferenci and Jean-Michel Pawlotsky

    Article first published online : 28 FEB 2013, DOI: 10.1002/hep.26179

  11. Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

    Phytotherapy Research

    Volume 29, Issue 7, July 2015, Pages: 1046–1053, Foroud Shahbazi, Sanambar Sadighi, Simin Dashti-Khavidaki, Farhad Shahi, Mehrzad Mirzania, Alireza Abdollahi and Mohammad-Hossein Ghahremani

    Article first published online : 7 APR 2015, DOI: 10.1002/ptr.5345

  12. Milk thistle in liver diseases: past, present, future

    Phytotherapy Research

    Volume 24, Issue 10, October 2010, Pages: 1423–1432, Ludovico Abenavoli, Raffaele Capasso, Natasa Milic and Francesco Capasso

    Article first published online : 7 JUN 2010, DOI: 10.1002/ptr.3207

  13. You have free access to this content
    Multiple effects of silymarin on the hepatitis C virus lifecycle


    Volume 51, Issue 6, June 2010, Pages: 1912–1921, Jessica Wagoner, Amina Negash, Olivia J. Kane, Laura E. Martinez, Yaakov Nahmias, Nigel Bourne, David M. Owen, Joe Grove, Claire Brimacombe, Jane A. McKeating, Eve-Isabelle Pécheur, Tyler N. Graf, Nicholas H. Oberlies, Volker Lohmann, Feng Cao, John E. Tavis and Stephen J. Polyak

    Article first published online : 12 FEB 2010, DOI: 10.1002/hep.23587

  14. Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate–caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1α expression in SENCAR mouse epidermis: Implications in the prevention of stage I tumor promotion

    Molecular Carcinogenesis

    Volume 26, Issue 4, December 1999, Pages: 321–333, Jifu Zhao, Yogesh Sharma and Rajesh Agarwal

    Article first published online : 22 NOV 1999, DOI: 10.1002/(SICI)1098-2744(199912)26:4<321::AID-MC11>3.0.CO;2-9

  15. Silymarin treatment of viral hepatitis: a systematic review

    Journal of Viral Hepatitis

    Volume 12, Issue 6, November 2005, Pages: 559–567, K. É. Mayer, R. P. Myers and S. S. Lee

    Article first published online : 29 JUN 2005, DOI: 10.1111/j.1365-2893.2005.00636.x

  16. You have free access to this content
    Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats

    International Journal of Cancer

    Volume 101, Issue 5, 10 October 2002, Pages: 461–468, Hiroyuki Kohno, Takuji Tanaka, Kunihiro Kawabata, Yoshinobu Hirose, Shigeyuki Sugie, Hiroyuki Tsuda and Hideki Mori

    Article first published online : 13 AUG 2002, DOI: 10.1002/ijc.10625

  17. Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C

    The Journal of Clinical Pharmacology

    Volume 50, Issue 4, April 2010, Pages: 434–449, Dr Roy L. Hawke, Dr Sarah J. Schrieber, Dr Tedi A. Soule, Dr Zhiming Wen, Dr Philip C. Smith, Dr K. Rajender Reddy, Dr Abdus S. Wahed, Dr Steven H. Belle, Dr Nezam H. Afdhal, Dr Victor J. Navarro, Dr Josh Berman, Dr Qi-Ying Liu, Dr Edward Doo, Dr Michael W. Fried and The SyNCH Trial Group

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009347475


    Journal of Food Biochemistry

    Volume 36, Issue 3, June 2012, Pages: 369–377, CHUNG-HSI CHOU, YI-CHEN CHEN, MENG-CHIEH HSU, WEI-LUN TSAI, CHIA-YI CHANG and CHIH-HSIEN CHIU

    Article first published online : 21 DEC 2011, DOI: 10.1111/j.1745-4514.2011.00543.x

  19. Influence of exogenous salicylic acid on flavonolignans and lipoxygenase activity in the hairy root cultures of Silybum marianum

    Cell Biology International

    Volume 33, Issue 9, September 2009, Pages: 988–994, Masumeh Khalili, Tahereh Hasanloo, Kazemi Seyyed Kamal Tabar and Hassan Rahnama

    Article first published online : 2 JAN 2013, DOI: 10.1016/j.cellbi.2009.06.003

  20. Silymarin inhibits melanin synthesis in melanocyte cells

    Journal of Pharmacy and Pharmacology

    Volume 61, Issue 5, May 2009, Pages: 663–667, Soo-Jin Choo, In-Ja Ryoo, Young-Hee Kim, Guang-Hwa Xu, Won-Gon Kim, Ki-Ho Kim, Seong-Joon Moon, Eui-Dong Son, KiHwan Bae and Dr Ick-Dong Yoo

    Article first published online : 8 JAN 2010, DOI: 10.1211/jpp.61.05.0016